Showing results (81-90 of 286) with videos related to
Sort By:
Pageof 29
Human Vaccines & Immunotherapeutics|May 21, 2026
Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product reviewJonathan E Cohen, Inderjit Mehmi, Mordechai Avner, et al.Cutis|September 6, 2017
Topical cannabinoids in dermatologyPeter W Hashim, Joel L Cohen, David T Pompei, et al.Journal of Cutaneous Pathology|December 22, 2007
Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattooGary Goldenberg, Shiv Patel, Manisha J Patel, et al.Cutis|May 1, 2019
The role of diet in preventing photoaging and treating common skin conditionsYssra S Soliman, Peter W Hashim, Aaron S Farberg, et al.Cutis|May 16, 2018
Update on noninvasive body contouring techniquesAlexandra K Rzepecki, Aaron S Farberg, Peter W Hashim, et al.Journal of Cutaneous Pathology|June 12, 2008
Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylateJohn Thomison, Martin McCarter, Damon McClain, et al.Cutis|September 6, 2019
Nonsurgical hair restoration treatmentRoya S Nazarian, Aaron S Farberg, Peter W Hashim, et al.Cancers|October 27, 2019
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for <i>BRAF</i>-Mutant MelanomaOmid Hamid, C Lance Cowey, Michelle Offner, et al.Nature Reviews. Clinical Oncology|April 26, 2022
Optimal systemic therapy for high-risk resectable melanomaAlexander M M Eggermont, Omid Hamid, Georgia V Long, et al.The American Journal of Dermatopathology|September 23, 2008
Bullous mastocytosis: report of a patient and a brief review of the literatureKristina Avshalumov, Rita Pichardo, Joseph L Jorizzo, et al.Pageof 29